Journal Article

Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression

Rivas-Grajales, Ana Maria, Murrough, James W, Mathew, Sanjay J, Robinson, Meghan E, Salas, Ramiro, Qi, Karen

2021

Overview

Abstract Background Ketamine’s potent and rapid antidepressant properties have shown great promise to treat severe forms of major depressive disorder (MDD). A recently hypothesized antidepressant mechanism of action of ketamine is the inhibition of N-methyl-D-aspartate receptor–dependent bursting activity of the habenula (Hb), a small brain structure that modulates reward and affective states. Methods Resting-state functional magnetic resonance imaging was conducted in 35 patients with MDD at baseline and 24 hours following treatment with i.v. ketamine. A seed-to-voxel functional connectivity (FC) analysis was performed with the Hb as a seed-of-interest. Pre-post changes in FC and the associations between changes in FC of the Hb and depressive symptom severity were examined. Results A reduction in Montgomery–Åsberg Depression Rating Scale scores from baseline to 24 hours after ketamine infusion was associated with increased FC between the right Hb and a cluster in the right frontal pole (t = 4.65, P = .03, false discovery rate [FDR]-corrected). A reduction in Quick Inventory of Depressive Symptomatology-Self Report score following ketamine was associated with increased FC between the right Hb and clusters in the right occipital pole (t = 5.18, P < .0001, FDR-corrected), right temporal pole (t = 4.97, P < .0001, FDR-corrected), right parahippocampal gyrus (t = 5.80, P = .001, FDR-corrected), and left lateral occipital cortex (t = 4.73, P = .03, FDR-corrected). Given the small size of the Hb, it is possible that peri-habenular regions contributed to the results. Conclusions These preliminary results suggest that the Hb might be involved in ketamine’s antidepressant action in patients with MDD, although these findings are limited by the lack of a control group.

• Publisher: Oxford University Press
• Subject: Administration, Intravenous / Adult / Antidepressants / Antidepressive Agents - administration & dosage / Antidepressive Agents - pharmacology / Care and treatment / Cerebral Cortex - diagnostic imaging / Cerebral Cortex - physiopathology / Connectome / Depression, Mental / Depressive Disorder, Major - diagnostic imaging / Depressive Disorder, Major - drug therapy / Depressive Disorder, Major - physiopathology / Depressive Disorder, Treatment-Resistant - diagnostic imaging / Depressive Disorder, Treatment-Resistant - drug therapy / Depressive Disorder, Treatment-Resistant - physiopathology / Diencephalon / Dosage and administration / Female / Habenula - diagnostic imaging / Habenula - physiopathology / Health aspects / Humans / Ketamine / Ketamine - administration & dosage / Ketamine - pharmacology / Magnetic Resonance Imaging / Male / Mental depression / Middle Aged / Neural circuitry / Outcome Assessment, Health Care / Pharmacology, Experimental / Physiological aspects / Regular s / Testing / Treatment resistance